Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

7.29EUR
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
€7.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,225
52-wk High
€17.90
52-wk Low
€5.61

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 0.86
Market Cap(Mil.): €284.01
Shares Outstanding(Mil.): 11.74
Dividend: --
Yield (%): --

Financials

  ERYP.PA Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -3.20 -- --
ROI: -- 8.91 13.83
ROE: -- 10.06 15.25

BRIEF-Erytech Pharma Presents New Erymethionase Preclinical Findings

* ERYTECH SAID ON MONDAY IT PRESENTED NEW ERYMETHIONASE PRECLINICAL FINDINGS AT 2019 AACR ANNUAL MEETING

02 Apr 2019

BRIEF- Erytech Pharma FY Total Operating Loss Widens To 43.6 Million Euros

* ANNOUNCED ON MONDAY, ERYTECH PROVIDES BUSINESS UPDATE AND REPORTS FINANCIAL RESULTS FOR FULL YEAR 2018

12 Mar 2019

BRIEF-ERYTECH Partners With New York Blood Center For Red Blood Cell Supply And Research

* NEW YORK BLOOD CENTER (NYBC)TO BECOME LONG-TERM SUPPLIER OF DONOR RED BLOOD CELLS (RBC) TO ERYTECH

16 Nov 2018

BRIEF-Erytech Pharma 9-Month Operating Loss Widens To 34.1 Million Euros

* ANNOUNCED ON MONDAY CASH POSITION OF EUR 146.9 MLN AS OF SEPT 30, 2018, COMPARED WITH EUR 185.5 MLN AS OF DEC 31, 2017

13 Nov 2018

Earnings vs. Estimates